These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34728779)

  • 21. Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug.
    Chinsriwongkul A; Chareanputtakhun P; Ngawhirunpat T; Rojanarata T; Sila-on W; Ruktanonchai U; Opanasopit P
    AAPS PharmSciTech; 2012 Mar; 13(1):150-8. PubMed ID: 22167418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers.
    Yang CR; Zhao XL; Hu HY; Li KX; Sun X; Li L; Chen DW
    Chem Pharm Bull (Tokyo); 2010 May; 58(5):656-61. PubMed ID: 20460792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
    Nagaich U; Gulati N
    Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity.
    Vieira R; Severino P; Nalone LA; Souto SB; Silva AM; Lucarini M; Durazzo A; Santini A; Souto EB
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32041134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
    Rathod VR; Shah DA; Dave RH
    Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Thermoresponsive Eyedrop Formulation Containing Ibuprofen Loaded-Nanostructured Lipid Carriers (NLC): Development, Characterization and Biocompatibility Studies.
    Almeida H; Lobão P; Frigerio C; Fonseca J; Silva R; Palmeira-de-Oliveira A; Lobo JM; Amaral MH
    Curr Drug Deliv; 2016; 13(6):953-70. PubMed ID: 26502890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tacrolimus-loaded lecithin-based nanostructured lipid carrier and nanoemulsion with propylene glycol monocaprylate as a liquid lipid: Formulation characterization and assessment of dermal delivery compared to referent ointment.
    Savić V; Ilić T; Nikolić I; Marković B; Čalija B; Cekić N; Savić S
    Int J Pharm; 2019 Oct; 569():118624. PubMed ID: 31419461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanostructured lipid carriers for site-specific drug delivery.
    Khosa A; Reddi S; Saha RN
    Biomed Pharmacother; 2018 Jul; 103():598-613. PubMed ID: 29677547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation development of lipid nanoparticles: Improved lipid screening and development of tacrolimus loaded nanostructured lipid carriers (NLC).
    Kovačević AB; Müller RH; Keck CM
    Int J Pharm; 2020 Feb; 576():118918. PubMed ID: 31870954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery.
    Varela-Fernández R; García-Otero X; Díaz-Tomé V; Regueiro U; López-López M; González-Barcia M; Isabel Lema M; Javier Otero-Espinar F
    Eur J Pharm Biopharm; 2022 Mar; 172():144-156. PubMed ID: 35183717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hybrid Nanostructured Films for Topical Administration of Simvastatin as Coadjuvant Treatment of Melanoma.
    Barone A; Mendes M; Cabral C; Mare R; Paolino D; Vitorino C
    J Pharm Sci; 2019 Oct; 108(10):3396-3407. PubMed ID: 31201905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orcinol Glucoside Loaded Polymer - Lipid Hybrid Nanostructured Lipid Carriers: Potential Cytotoxic Agents against Gastric, Colon and Hepatoma Carcinoma Cell Lines.
    Nahak P; Gajbhiye RL; Karmakar G; Guha P; Roy B; Besra SE; Bikov AG; Akentiev AV; Noskov BA; Nag K; Jaisankar P; Panda AK
    Pharm Res; 2018 Aug; 35(10):198. PubMed ID: 30151753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development, characterization and pharmacokinetics of mupirocin-loaded nanostructured lipid carriers (NLCs) for intravascular administration.
    Alcantara KP; Zulfakar MH; Castillo AL
    Int J Pharm; 2019 Nov; 571():118705. PubMed ID: 31536765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation.
    Scioli Montoto S; Sbaraglini ML; Talevi A; Couyoupetrou M; Di Ianni M; Pesce GO; Alvarez VA; Bruno-Blanch LE; Castro GR; Ruiz ME; Islan GA
    Colloids Surf B Biointerfaces; 2018 Jul; 167():73-81. PubMed ID: 29627680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
    Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
    Noor NM; Sheikh K; Somavarapu S; Taylor KMG
    Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.
    Rizwanullah M; Amin S; Ahmad J
    J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electron Paramagnetic Resonance and Small-Angle X-ray Scattering Characterization of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Dibucaine Encapsulation.
    Barbosa RM; Casadei BR; Duarte EL; Severino P; Barbosa LRS; Duran N; de Paula E
    Langmuir; 2018 Nov; 34(44):13296-13304. PubMed ID: 30299102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells.
    Costa CP; Cunha S; Moreira JN; Silva R; Gil-Martins E; Silva V; Azevedo L; Peixoto AF; Sousa Lobo JM; Silva AC
    Int J Pharm; 2021 Sep; 607():120933. PubMed ID: 34324988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors.
    Banerjee P; Geng T; Mahanty A; Li T; Zong L; Wang B
    Int J Pharm; 2019 Feb; 557():374-389. PubMed ID: 30610896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.